New decision from the District Court for the Eastern District of New York finds that the FDA has exclusive authority to determine whether OTC drugs are effective. Court found that manufacturers of OTC drugs do not have an obligation to unilaterally update the label’s efficacy claims based on new information….
By: Dechert LLP
By: Dechert LLP
